NHSA Launches 2023 NRDL Update Process with New Work Plan and Public Feedback Period
The National Healthcare Security Administration (NHSA) has commenced the process for the annual update of...
NHSA (prev. SMIA)
Eccogene Secures $25 Million in Series B Financing to Advance Metabolic Disease Therapies
Sino-US firm Eccogene Inc. has announced the closure of a Series B financing round, raising...
Hainan Province and NHSA Partner to Enhance Medical Insurance Industry with Real-World Data
The government of Hainan province has entered into a strategic partnership with the National Healthcare...
NHSA Proposes Draft to Enhance Basic Medical Insurance Payment Management for Consumables
The National Healthcare Security Administration (NHSA) has issued a Notice seeking public feedback on draft...
China’s NHC and 13 Bureaus Launch Campaign to Rectify Pharmaceutical and Medical Services Practices
The National Health Commission (NHC) along with 13 other bureaus has jointly released a notification...
Chinese Authorities Launch Special Campaign to Combat Fraud in Medical Insurance
The National Healthcare Security Administration, Supreme People’s Procurator, Ministry of Public Security, Ministry of Finance,...
China’s NHSA Introduces Tiered Pricing for COVID-19 Therapies: A, B, and C Categories
The National Healthcare Security Administration (NHSA) has issued a Notification concerning the improvement of the...
NHSA Launches Crackdown on Medical Insurance Fund Management with New Inspection Measures
The National Healthcare Security Administration (NHSA) is intensifying efforts to manage medical insurance funds at...
NHSA’s 2022 Healthcare Security Bulletin Reveals Break-Even Performance
The National Healthcare Security Administration (NHSA) has released its annual “Healthcare Security Development Statistical Bulletin”...
NHSA’s 2022 Healthcare Security Report Reveals Break-Even Performance
The National Healthcare Security Administration (NHSA) has released its annual “Healthcare Security Development Statistical Bulletin”...
China Releases Blue Book on Medical Insurance Fund Supervision
The China Health Insurance and Social Sciences Academic Press has jointly released the “Blue Book...
NHSA Releases Guidelines on Drug Procurement and Pricing Management
The National Healthcare Security Administration (NHSA) has released a notification regarding provincial centralized procurement and...
NHSA Updates 2022 National Reimbursement Drug List with 2,967 Drug Varieties
The National Healthcare Security Administration (NHSA) has revealed the results of the 2022 National Reimbursement...
NHSA Completes 2022 NRDL Update with 111 New Listings, Focus on COVID-19 Treatments
The National Healthcare Security Administration (NHSA) held a press conference to mark the completion of...
China Optimizes Medical Insurance Policies for COVID-19 Treatment
The National Healthcare Security Administration (NHSA), Ministry of Finance, National Health Commission, and Chinese Center...
Pfizer’s Paxlovid Excluded from China’s NRDL Amid Price Dispute
The National Reimbursement Drug List (NRDL) negotiations have concluded, with Pfizer’s (NYSE: PFE) COVID-19 therapy...
NHSA and CNIPA Issue Opinions on Strengthening IP Protection in Drug Procurement
The National Healthcare Security Administration (NHSA) and the China National Intellectual Property Administration (CNIPA) have...
NHSA Orders Investigation into Unreasonable Medical Insurance Restrictions
The National Healthcare Security Administration (NHSA) has released a notification to medical insurance departments across...
NHSA Delays NRDL Negotiations Due to COVID-19 Disruptions
The National Healthcare Security Administration (NHSA) announced that it has been decided to delay the...
NHSA Responds to Proposal on Dental Implants’ Inclusion in NRDL
The National Healthcare Security Administration (NHSA) has responded to the No. 6184 suggestion from the...